Sejong Medical Co., Ltd.

KOSDAQ:A258830 주식 보고서

시가총액: ₩23.0b

Sejong Medical 미래 성장

Future 기준 확인 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Sejong Medical.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Medical Equipment 수익 성장33.5%
매출 성장률n/a
향후 자기자본 수익률n/a
애널리스트 커버리지

None

마지막 업데이트n/a

최근 미래 성장 업데이트

업데이트 없음

Recent updates

Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively

Mar 24
Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively

Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year

Mar 02
Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year

Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?

Feb 11
Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?

We're Not Counting On Sejong Medical (KOSDAQ:258830) To Sustain Its Statutory Profitability

Jan 27
We're Not Counting On Sejong Medical (KOSDAQ:258830) To Sustain Its Statutory Profitability

Is Sejong Medical Co., Ltd. (KOSDAQ:258830) A Smart Choice For Dividend Investors?

Jan 12
Is Sejong Medical Co., Ltd. (KOSDAQ:258830) A Smart Choice For Dividend Investors?

Income Investors Should Know That Sejong Medical Co., Ltd. (KOSDAQ:258830) Goes Ex-Dividend Soon

Dec 25
Income Investors Should Know That Sejong Medical Co., Ltd. (KOSDAQ:258830) Goes Ex-Dividend Soon

Should We Be Excited About The Trends Of Returns At Sejong Medical (KOSDAQ:258830)?

Dec 23
Should We Be Excited About The Trends Of Returns At Sejong Medical (KOSDAQ:258830)?

These 4 Measures Indicate That Sejong Medical (KOSDAQ:258830) Is Using Debt Reasonably Well

Dec 08
These 4 Measures Indicate That Sejong Medical (KOSDAQ:258830) Is Using Debt Reasonably Well

The Sejong Medical (KOSDAQ:258830) Share Price Has Gained 42% And Shareholders Are Hoping For More

Nov 19
The Sejong Medical (KOSDAQ:258830) Share Price Has Gained 42% And Shareholders Are Hoping For More

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Sejong Medical 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

KOSDAQ:A258830 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (KRW Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
3/31/202419,101-71,605-1,5671,511N/A
12/31/202317,992-23,0876612,763N/A
12/31/202216,083-91,366-1,332-429N/A
9/30/202216,931-5,411-14,459-9,778N/A
6/30/202213,361-5,375-14,137-9,540N/A
3/31/202217,759-6,111-14,040-9,376N/A
12/31/202118,021-5,192-12,999-8,349N/A
9/30/202117,703-1,762-901,195N/A
6/30/202117,079-985-474675N/A
3/31/202115,881-64441,096N/A
12/31/202015,098470-1,365191N/A
9/30/202015,4651,682-4,0061,587N/A
6/30/202015,2382,668-2,8013,662N/A
3/31/202015,8293,173-4,1674,034N/A
12/31/201916,2303,464-3,8504,480N/A
9/30/201915,9243,636234,786N/A
6/30/201915,9273,9423694,624N/A
3/31/201915,3093,6956483,235N/A
12/31/201814,8333,787-921,840N/A
9/30/201813,6222,3151,7642,668N/A
6/30/201814,1022,5161,4901,981N/A
3/31/201814,4733,1672,4693,058N/A
12/31/201714,5503,214N/A4,324N/A
12/31/201612,7733,169N/A3,925N/A
12/31/201511,9571,550N/A3,306N/A

애널리스트 미래 성장 예측

수입 대 저축률: Insufficient data to determine if A258830's forecast earnings growth is above the savings rate (2.5%).

수익 vs 시장: Insufficient data to determine if A258830's earnings are forecast to grow faster than the KR market

고성장 수익: Insufficient data to determine if A258830's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: Insufficient data to determine if A258830's revenue is forecast to grow faster than the KR market.

고성장 수익: Insufficient data to determine if A258830's revenue is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if A258830's Return on Equity is forecast to be high in 3 years time


성장 기업 발견